Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients
{{output}}
Background: The FAST-Forward trial demonstrated the non-inferiority of 26 Gy in five fractions compared to 40 Gy in 15 fractions over five years. This study aimed to report observed breast toxicities and examine the impact of dos... ...
